SEC Form 4 · accession 0001019687-15-001299
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrey Semechkin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Mar 31, 2015
Accepted (ET)
Apr 2, 2015 · 7:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2015 | P | 5,894,214 | $0.0448 | A | 60,143,521 | D | |
| Common StockF1 | holding | — | — | — | 8,000,000 | I | By Corporation |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series C Warrant (Right to Buy) | $0.0448 | Mar 31, 2015 | C | 5,894,214 | D | Oct 14, 2014 | Apr 14, 2015 | Common Stock | 5,894,214 | 0 | D |
Explanation of responses
- F1Common Stock is owned by X-Master, Inc., a New Hampshire Corporation of which the reporting person is a sole shareholder.